Stepan Company (SCL)
Stepan Increases Quarterly Cash Dividend, Marking the 58th Consecutive Year of Increases
EyePoint Pharmaceuticals Inc (EYPT)
EyePoint to Report Third Quarter 2025 Financial Results on November 5, 2025
Stepan Company (SCL)
Stepan Reports Third Quarter 2025 Results
Bausch&Lomb Corp (BLCO)
Bausch + Lomb Announces Third-Quarter 2025 Results
Merck & Company Inc (MRK)
European Commission Approves KEYTRUDA® (pembrolizumab) as Part of a Treatment Regimen for Adults with Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Expressing PD-L1 (CPS >1)
Immunic Inc (IMUX)
Immunic to Participate in Industry and Investor Conferences in November
United Therapeutics Corporation (UTHR)
United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results
COMPASS Pathways plc (CMPS)
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors
GE HealthCare Technologies Inc (GEHC)
GE HealthCare reports third quarter 2025 financial results
Avantor Inc. (AVTR)
Avantor® Reports Third Quarter 2025 Results